Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimization of Inflammatory Bowel Disease Treatment Through Understanding of Gut Virome Heterogeneity and the Potential for Bacteriophage-based Therapy

NCT07240181 is registered in ClinicalTrials.gov with Andreas Munk Petersen as lead sponsor.

NCT NCT07240181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07240181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimization of Inflammatory Bowel Disease Treatment Through Understanding of Gut Virome Heterogeneity and the Potential for Bacteriophage-based Therapy
Lead sponsor
Andreas Munk Petersen
Phase
Observational
Overall status
Not yet recruiting
Start date
December 1, 2025
Completion date
December 31, 2029
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colitis ulcerative, crohns disease, ibd (inflammatory bowel disease)